泰格医药（03347）今日盘中大涨8.91%，引发市场关注。该股价上涨主要受到公司最新发布的2025年第三季度财报利好消息推动。
根据泰格医药发布的2025年第三季度财报显示，公司整体业绩表现强劲。尽管前三季度营业总收入为50.26亿元，同比小幅下降0.82%，但归属于母公司股东的净利润达到10.2亿元，同比大幅增长25.45%。更值得注意的是，单看第三季度数据，公司业绩增长更为显著。第三季度营业总收入达17.75亿元，同比增长3.86%；归属于母公司股东的净利润高达6.37亿元，同比劲增98.73%。
分析人士指出，泰格医药第三季度净利润的大幅增长可能是推动股价上涨的主要原因。这一业绩表现反映出公司在提高盈利能力和运营效率方面取得了显著成效。然而，投资者也应注意到公司应收账款规模较大，当期应收账款占最新年报归母净利润比达352.26%，这可能会对公司的现金流造成一定压力。总体来看，泰格医药的业绩增长势头强劲，但仍需关注应收账款管理等财务指标。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.